Table 4 Tabular presentation for agreement of ROBIS results
From: A comparison of two assessment tools used in overviews of systematic reviews: ROBIS versus AMSTAR-2
Fibromyalgia review | Phase 2 | Phase 3 | |||
1. Study eligibility criteria | 2. Identification and selection of studies | 3. Data collection and study appraisal | 4. Synthesis and findings | 5. Risk of bias in the review | |
 Homoeopathy | |||||
  1. Perry | Low | Low | Low | Unclear | Low |
  2. Boehm | High | Low | Low | High | High |
 Acupuncture | |||||
  3. Mayhew | Low | High | High | Low | Low |
  4. Daya | Low | High | High | Low | Low |
  5. Langhorst | Low | High | High | Low | Low |
  6. Martin-Sanchez | Low | High | High | High | High |
  7. Cao | Low | High | Low | Low | Low |
  8. Deare | Low | Low | Low | Low | Low |
  9. Yang | Low | Low | High | High | High |
 Chiropractic | |||||
  10. Ernst | High | Unclear | High | Unclear | Unclear |
 Herbal Medicine | |||||
  11. Nascimento | Low | Low | Low | High | Low |
 Multiple CAM reviews | |||||
  12. Holdcraft | Low | Low | Low | High | Low |
  13. Baronowsky | Low | Low | Unclear | High | Low |
  14. Terhorst | Low | High | Low | High | High |
  15. De Silva | High | High | High | Unclear | Low |
Colic review | Phase 2 | Phase 3 | |||
1. Study eligibility criteria | 2. Identification and selection of studies | 3. Data collection and study appraisal | 4. Synthesis and findings | 5. Risk of bias in the review | |
 Multiple CAM therapies | |||||
  1. Perry | Low | Unclear | Low | Low | Low |
  2. Bruyas-Bertholon | High | High | Unclear | High | High |
  3. Harb | High | High | Low | High | High |
  4. Gutierrez-Castrellon | Unclear | High | High | High | High |
 Manipulation therapies | |||||
  5. Dobson | Low | Low | Low | Low | Low |
  6. Gleberzon | High | High | Unclear | Unclear | High |
  7. Carne | Low | Low | Low | High | Unclear |
 Acupuncture | |||||
  8. Skejeie | Low | Low | Low | Low | Unclear |
 Herbal medicine | |||||
  9. Anheyer | Unclear | High | Low | High | High |
 Probiotics | |||||
  10. Sung 2013 | Unclear | Low | Low | High | Unclear |
  11. Anabrees | Low | Low | Low | High | Low |
  12. Urbansk | Low | High | High | High | High |
  13. Xu | Unclear | Low | Low | Unclear | Low |
  14. Shreck Bird | High | High | Low | High | High |
  15. Dryl | High | High | Unclear | High | High |
  16. Sung 2018 | High | Unclear | Unclear | Unclear | Unclear |